Associate Director – Consumer Marketing, IBU alliances at Eli Lilly and Company

Bryanston, Gauteng, South Africa

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Relevant bachelor’s Degree
Minimum five years of consumer marketing and analytics experience
Experience in leading different patient activation/consumer projects
Equivalent marketing/industry experience
Relevant education and experience in consumer marketing
Proven track record in designing and executing consumer marketing strategies
Ability to work in an agile team environment and adapt to shifting business priorities
Preferences
Previous experience leading or significantly participating in digital campaign development and media plan strategy and execution
Ability to be data-driven (inferred from truncated description)

Responsibilities

Represent needs of IBU alliance markets and requests from D&P alliance partners on newer capabilities of consumer marketing and B2B play with Global/IBU central teams
Partner with Lilly global marketing and IBU central teams to understand global DSE campaigns and WGLL for successful execution of these campaigns; enable D&P partners with these WGLL and best practices and cascade these learnings
Establish frameworks, structure, processes, and governance for working with Alliance partners; put together governance process to monitor success of various DSE campaigns of prioritized D&P partners – coach them on areas of opportunity and provide guidance on their requests to ensure best-in-class launch of these DSE campaigns
Build capabilities of D&P partners to elevate integrated consumer-first marketing and PESO strategies
Share best practices across Alliance partners and geographies
Operate in an agile team concept to execute responsibilities across therapy areas

Skills

Consumer Marketing

Marketing Strategy

PESO Media

Disease State Education

Go-to-Market Strategy

Alliance Management

Media Planning

Strategic Governance

Knowledge Transfer

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free